Clinical TrialsSearch results
Number of results: 945
Not yet recruiting
- A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
- Multiple Myeloma
- Takizawa Manami
- 2026-02-13
Recruiting
- JCOG2402: A randomized phase III study of response-guided therapy in premenopausal patients with early breast cancer
- ER-positive, HER2-negative invasive breast cancer
- KANEMITSU Yukihide
- 2026-01-27
Recruiting
- A Study on the Efficacy of Air-Pressure Pump-Assisted Lymphatic Drainage Following Lymphatic-Venous Anastomosis
- Secondary lower extremity lymphedema
- Akita Shinsuke
- 2025-12-24
Recruiting
- A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
- PIK3CA-mutated HER2-positive locally advanced or metastatic breast cancer
- Fabiola Amair-Pinedo
- 2025-12-17
Recruiting
- A Phase I/II exploratory clinical trial to evaluate the efficacy and safety of RBBM-S1 in patients requiring lumbar interbody fusion for degenerative lumbar disease, in comparison with the standard treatment of autologous bone grafting.
- lumbar stenosis, spondylolisthesis, spondylolysis, scoliosis, instability, disc disease
- Tokuyama Ryusuke
- 2025-12-16
Not yet recruiting
- Early-phase Study of Claudin18.2 Peptide Diagnostic Radiopharmaceuticals
- Gastric Cancer
- Inaki Anri
- 2025-12-10
Recruiting
- Evaluating the Performance of an AI-Based Dermoscopic Image Analysis System for Supporting Skin Tumor Diagnosis
- Skin tumors and lesions requiring differentiation from skin tumors
- Togawa Yaei
- 2025-12-05
Recruiting
- Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Pulmonary hypertension, interstitial lung disease
- Makulova Natalya
- 2025-11-17
Recruiting
- Phase III, Randomized, Open-label, Global, Multicenter Study of Rilvegostomig or Durvalumab in Combination With Chemotherapy as a First-line Treatment for Patients With Advanced Biliary Tract Cancer
- Biliary Tract Cancer
- Hibi Kazushige
- 2025-11-11
Recruiting
- A Single-Center Randomized Controlled Trial Evaluating the Impact of SigniaTM Slow Mode on Exudative Hemorrhage After Pulmonary Vessel Disection.
- Diseases requiring anatomical lobectomy or segmentectomy
- Suzuki Hidemi
- 2025-10-29